Histological prevalence of β2-microglobulin amyloidosis in hemodialysis: A prospective post-mortem study

Kidney International

Volumn 51, Issue 6, 1997, Pages 1928-1932

  Jadoul, Michel ^a   Garbar, Christian ^b   Noël, Henri ^b   Sennesael, Jacques ^b   Vanholder, Raymond ^b   Bernaert, Pascale ^b   Rorive, Georges ^b   Hanioue, Geneviève ^b   Van Ypersele De Strihou, Charles ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN;

ADULT; AGED; ARTICLE; AUTOPSY; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY AMYLOIDOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0030941823     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.262     Document Type: Article

References (24)

1. VAN YPERSELE DE STRIHOU C, JADOUL M, MALGHEM J, MALDAGUE B, JAMART J, THE WORKING PARTY ON DIALYSIS AMYLOIDOSIS: Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 39:1012-1019, 1991
2. CHARRA B, CALEMARD E, LAURENT G: Chronic renal failure treatment duration and mode: Their relevance to the late dialysis periarticular syndrome. Blood Purif 6:117-124, 1988
3. STONE W: β2-microglobulin associated amyloidosis and end-stage renal disease, in Principles and Practice of Dialysis, edited by HENRICH WL, Baltimore, Williams and Wilkins, 1994, pp 225-233
4. KOCH KM: Dialysis-related amyloidosis. (Nephrology Forum) Kidney Int 41:1416-1429, 1992
5. HAKIM RM: Clinical implications of hemodialysis membrane biocompatibility. (Perspectives in Clinical Nephrology) Kidney Int 44:484-494, 1993
6. MIYATA T, INAGI R, IIDA Y, SATO M, YAMADA N, ODA O, MAEDA K, SEO H: Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. J Clin Invest 93:521-528, 1993
7. JADOUL M, NOEL H, VAN YPERSELE DE STRIHOU C: β2-m amyloidosis in a patient treated exclusively by CAPD. Am J Kidney Dis 15:86-88, 1990
8. JADOUL M, NOEL H, MALGHEM J, GALANT C, VAN YPERSELE DE STRIHOU C: Histological beta-2-microglobulin amyloidosis 10 years after a successful renal transplantation. Am J Kidney Dis 27:888-890, 1996
9. GOFFIN YA, THOUA Y, POTVLIEGE PR: Microdeposition of amyloid in the joints. Ann Rheum Dis 40:27-33, 1981
10. LACHENBRUCH PA: Discriminant Analysis. New York, Hafner Press, 1975
11. STEIN G, SCHNEIDER A, THOSS K, RITZ E, LINKE RP, SCHAEFER K, SPERSCHNEIDER H, ABENDROTH K, FÜNFSTÜCK R: Beta-2-microglobulin-derived amyloidosis: Onset, distribution and clinical features in 13 hemodialysed patients. Nephron 60:274-280, 1992
12. ATHANASOU NA, AYERS D, RAINEY AJ, OLIVER DO, DUTHIE RB: Joint and systemic distribution of dialysis amyloid. Quart J Med 78:205-214, 1991
13. HAMPL H, LOBECK H, BARTEL-SCHWARZ ES, STEIN H, EULITZ M, LINKE RP: Clinical, morphologic, biochemical and immunohistochemical aspects of dialysis-associated amyloidosis. Trans Am Soc Artif Intern Organs 33:250-259, 1987
14. ZINGRAFF J, NOËL LH, BARDIN T, KUNTZ D, DUBOST C, DRÜEKE T: β2-microglobulin amyloidosis: A sternoclavicular joint biopsy study in hemodialysis patients. Clin Nephrol 33:94-97, 1990
15. EHLERDING G, FLOEGE J, DROMMER W, KOCH KM: No evidence for inflammatory or fibrotic synovial changes prior to deposition of dialysis related amyloidosis. (abstract) J Am Soc Nephrol 4:344, 1993
16. OHASHI K, HARA M, KAWAI R, OGURA Y, HONDA K, NIHEI H, MIMURA N: Cervical discs are most susceptible to beta-2-microglobulin amyloid deposition in the vertebral column. Kidney Int 41:1646-1652, 1992
17. SCHAEFFER J, EHLERDING G, BURCHERT W, FLOEGE J, SHALDON S, KOCH KM: Relationship of scintigraphically proven dialysis-related amyloidosis (DRA) to age and time on hemodiaysis (HD). (abstract) J Am Soc Nephrol 3:392, 1992
18. SELL DR, MONNIER VM: End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 85:380-384, 1990
19. HOU FF, CHERTOW GM, BOYCE J, LAZARUS JM, BRAATZ J, OWEN WF JR: Binding of β2-microglobulin to collagen modified with advanced glycation end products. (abstract) J Am Soc Nephrol 7:1482, 1996
20. VAN YPERSELE DE STRIHOU C, FLOEGE J, JADOUL M, KOCH KM: Amyloidosis and its relationship to different dialysers. Nephrol Dial Transplant 9(Suppl 2):156-161, 1994
21. MAKITA Z, BUCALA R, RAYFEILD EJ, FRIEDMAN EA, KAUFMAN AM, KORBET SM, BARTH RH, WINSTON JA, FUH H, MANOGUE KR, CERAMI A, VLASSARA H: Reactive glycosylation end-products in diabetic uraemia and treatment of renal failure. Lancet 343:1519-1522, 1994
22. AOIKE I, GEJYO F, ARAKAWA M, NIIGATA RESEARCH PROGRAMME FOR B2-M REMOVAL MEMBRANE: Learning from the Japanese Registry: How will we prevent long-term complication? Nephrol Dial Transplant 10(Suppl 7):7-15, 1995
23. 2-microglobulin. Kidney Int 38:1169-1176, 1990
24. JADOUL M, MALGHEM J, VANDE BERG B, VAN YPERSELE DE STRIHOU C: Ultrasonographic detection of thickened joint capsules and tendons as marker of dialysis-related amyloidosis: A cross-sectional and longitudinal study. Nephrol Dial Transplant 8:1104-1109, 1993